You are here

  • Home
  • Archive
  • Volume 9, Issue 2
  • In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity

Article metrics

Article menu

This article has a correction. Please see:

XML
Clinical/translational cancer immunotherapy
Original research
In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity

 

Online download statistics by month:

Online download statistics by month: February 2021 to March 2026

AbstractFullPdf
Feb 202135635688
Mar 2021340340106
Apr 2021989858
May 202112912958
Jun 202113813851
Jul 202110810818
Aug 202110310319
Sep 2021858531
Oct 202111911947
Nov 2021868640
Dec 2021858523
Jan 2022737724
Feb 2022667227
Mar 202210511937
Apr 2022535820
May 2022586129
Jun 2022727526
Jul 2022525818
Aug 2022727221
Sep 2022496122
Oct 2022545514
Nov 2022505217
Dec 2022454522
Jan 2023485034
Feb 2023818226
Mar 2023545622
Apr 2023414236
May 2023545524
Jun 2023323816
Jul 2023353624
Aug 2023333321
Sep 2023313118
Oct 2023586027
Nov 202310810825
Dec 202314014125
Jan 2024414222
Feb 2024545526
Mar 2024565848
Apr 2024414135
May 2024444535
Jun 2024444320
Jul 2024495123
Aug 2024787725
Sep 2024575829
Oct 2024454726
Nov 2024363721
Dec 2024545513
Jan 2025505025
Feb 202510310324
Mar 2025666637
Apr 2025919140
May 2025484926
Jun 2025434420
Jul 2025110
Aug 2025110
Nov 2025110
Dec 2025100
Feb 2026110
Mar 2026110
Total411742011609